At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 181 enrolled
Drug / intervention
avanafil +1 moredrug
Likely dose
avanafil 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Clinical Trial of the Effect of Avanafil (STENDRA™) on Spermatogenesis in Healthy Adult Males and Adult Males With Mild Erectile Dysfunction
In Brief
A Phase 4 clinical trial evaluating avanafil and Placebo for Erectile Dysfunction. Completed, enrolled 181 participants across 15 sites.
Detailed Summary
The purpose of this study is to determine whether avanafil will affect different aspects of sperm production.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsErectile Dysfunction
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2012
First PostedJan 2013
Primary CompletionAug 2014
TodayJul 2026
First PostedJan 15, 2013
Enrollment StartDec 1, 2012
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 13.5 years ago
Interventions
avanafildrug
100 mg
Placebodrug